|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02415 MEDSCI
Nominal 
0.760 -0.005 (-0.654%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 117,451 | -6.224% | 270,374 | 260,623 | 349,194 | 348,950 |
| Cost of Sales | (56,121) | 17.489% | (109,929) | (98,449) | (132,587) | (142,629) |
| Gross Profit | 61,330 | -20.843% | 160,445 | 162,174 | 216,607 | 206,321 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (9,026) | 21.759% | (13,198) | (14,180) | (831) | (111,884) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 10,441 | -28.097% | 19,524 | 25,497 | 60,450 | (96,292) | |
| Taxation | 197 | -- | (1,587) | (530) | (5,408) | (3,589) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 10,638 | -19.646% | 17,937 | 24,967 | 55,042 | (99,881) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (2,664) | -63.056% | (8,385) | (16,045) | (15,095) | (10,022) |
| Depreciation & Amortisation | 2,624 | -14.276% | 5,626 | 7,195 | 8,350 | 8,378 |
| Directors' Emoluments | -- | -- | -- | 21,309 | 5,351 | 3,650 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 1.940 | -20.816% | 3.000 | 5.000 | 11.000 | -21.000 |
| DPS (cts) | 0.000 | -- | 0.964 | 0.000 | 0.000 | -- |
| Dividend Payout Ratio (%) | -- | -- | 32.139% | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.004 | 0.101 | 0.073 | (0.030) |
| NBV per share ($) | 1.912 | -- | 1.945 | 1.926 | 1.845 | -- |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 10,638 |
| %Change | -19.646% |
| EPS / (LPS) | RMB 0.019 |
| NBV Per Share (¥) | RMB 1.912 |